Chemotherapy: a double-edged sword in cancer treatment
2021 · Cancer Immunology Immunotherapy · 348 citations
https://doi.org/10.1007/s00262-021-03013-3
R
Reza Zolfaghari Emameh
National Institute of Genetic Engineering and Biotechnology(IR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
77
Papers
1.6K
Citations
21
h-index
37
i10-index
Reza Zolfaghari Emameh is an academic researcher from National Institute of Genetic Engineering and Biotechnology. The author has contributed to research in topics: Enzyme function and inhibition & Research on Leishmaniasis Studies & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 21, co-authored 66 publications.
ORCID: 0000-0002-3253-7844Papers by this author
worksPhytochemicals as Modulators of Long Non-Coding RNAs and Inhibitors of Cancer-Related Carbonic Anhydrases
2019 · International Journal of Molecular Sciences · 55 citations
https://doi.org/10.3390/ijms20122939
Improving the mechanical behavior of reduced graphene oxide/hydroxyapatite nanocomposites using gas injection into powders synthesis autoclave
2020 · Scientific Reports · 34 citations
https://doi.org/10.1038/s41598-020-64928-y
Expansion of Single Cell Transcriptomics Data of SARS-CoV Infection in Human Bronchial Epithelial Cells to COVID-19
2020 · Biological Procedures Online · 34 citations
https://doi.org/10.1186/s12575-020-00127-3
Cytokine profile and nitric oxide levels in peritoneal macrophages of BALB/c mice exposed to the fucose-mannose ligand of Leishmania infantum combined with glycyrrhizin
2020 · Parasites & Vectors · 14 citations
https://doi.org/10.1186/s13071-020-04243-7
Characteristics of hydroxyapatite-reduced graphene oxide composite powders synthesized via hydrothermal method in the absence and presence of diethylene glycol
2021 · Open Ceramics · 14 citations
https://doi.org/10.1016/j.oceram.2021.100067
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat